Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Human Gene Therapy|April 23, 2010
Development of adoptive cell therapy for cancer: a clinical perspectiveRobert E Hawkins, David E Gilham, Reno Debets, et al.Diseases of the Colon and Rectum|June 10, 2003
Gene therapy of patient-derived T lymphocytes to target and eradicate colorectal hepatic metastasesAali J Sheen, Joely Irlam, Natalia Kirillova, et al.Pancreas|December 13, 2005
A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?Alison J Clayton, Abdul W Mansoor, Eileen T Jones, et al.Clinical Prostate Cancer|October 4, 2005
Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancerRobert E Hawkins, Luc Daigneault, Richard Cowan, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitopeAnne C Armstrong, Said Dermime, Christopher G Allinson, et al.Journal of Vascular Surgery|January 2, 2019
Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severityVincent J Noori, Christopher T Healey, Jens Eldrup-Jorgensen, et al.Biochimica Et Biophysica Acta|July 9, 2004
Vaccine and antibody-directed T cell tumour immunotherapySaid Dermime, David E Gilham, David M Shaw, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinomaChristy Ralph, Eyad Elkord, Deborah J Burt, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferon-alphaRobert E Hawkins, Catriona Macdermott, Alaaeldin Shablak, et al.Cancer Chemotherapy and Pharmacology|April 19, 2007
A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinomaRobert J Jones, Robert E Hawkins, Martin M Eatock, et al.Pageof 8